MedTrace Logo

A New Minimal-invasive Brain Tissue Probe Applying Near Infrared Spectroscopy

NCT01801306 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2014-06-18

No results posted yet for this study

Summary

To assess the feasibility of a new brain tissue probe for multi-parameter neuromonitoring (NeMo Probe) and the accuracy of measurement values.

To demonstrate the ability of the NeMo probe to detect changes in cerebral hemodynamics and oxygenation during cerebrovascular events monitored with established methods including brain tissue oxygenation tension and microdialysis

Conditions

  • Spontaneous Subarachnoid Hemorrhage

Interventions

DEVICE

NeMo Probe

A new minimal-invasive brain tissue probe applying near infrared spectroscopy

Sponsors & Collaborators

  • NeMoDevices AG

    lead INDUSTRY

Principal Investigators

  • Martin Seule, MD · Department of Neurosurgery, University Hospital Heidelberg

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01801306 on ClinicalTrials.gov